Dermatology Devices Market Is Expected To Grow At A CAGR Of 12.7%From 2014 To 2025: Grand View Research, Inc.

The global dermatology devices market is expected to reach a value of USD 25.7 billion by 2025, according to a new report by Grand View Research, Inc. Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding esthetics. This has led to rising awareness about various types of esthetic procedures used for treating hair- and skin-related disorders. Primarily, women suffer from these disorders. Hence, they are considered as the highest revenue generators for the market.

Incidence of skin disorders is continuously rising amongst people owing to their irregular lifestyle and food habits. Skin disorders such as psoriasis, acne, eczema, and skin lesions are some of the common skin ailments amongst people. Melanoma is a life-threatening skin cancer, which often results due to these skin disorders. Dermatology diagnostic devices help in the early diagnosis of such deadly cancerous diseases.

Obesity has become one of the major issues for both the male and female population. Hence, fat removal procedures are being highly adopted. Liposuction is considered as an effective treatment for obese people. Moreover, the geriatric population is also highly concerned about their esthetic appearance. In order to enhance their esthetic appeal, they go for skin tightening and wrinkle removal procedures. In addition, technological advancements in laser treatments are continuously growing for dermatology devices market, which is making it a lucrative field for people concerned with esthetics.

Browse full research report on Dermatology Devices Market: http://www.grandviewresearch.com/industry-analysis/dermatology-devices-market

Further key findings from the study suggest:

  • Imaging devices dominated the market in 2015 due to high incidence of skin cancer and technological advancements in related products
  • Light therapy devices held the largest market share in 2015 due to its wide usability by dermatologists for skin lesion treatment
  • Skin cancer diagnosis was the highest revenue generator segment in 2015 owing to the high prevalence of skin cancer, particularly, melanoma
  • Vascular and pigmented lesion removal dominated the market in 2015 due to the high susceptibility of vascular lesion leading to skin tumor
  • Acne, psoriasis, and tattoo removal is expected to gain lucrative growth over the forecast period due to growing number of people experiencing acne related problems
  • North America dominated in 2015 owing to the high penetration of light therapy and laser-based instruments in the field of dermatology devices and skin rejuvenation
  • Some of the key companies include Cynosure, Inc., LUMENIS, Valeant Pharmaceuticals International Inc., Alma Lasers, Ltd., Cutera, Inc., Syneron Medical Ltd., and Avita Medical Ltd.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the dermatology devices market on the basis of diagnostic devices (type and application), treatment devices (type and application), and region:

Dermatology Devices Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Diagnostic Devices
  • Treatment Devices
Dermatology Diagnostic Devices Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Imaging Devices
  • Dermatoscopes
  • Microscopes
Dermatology Diagnostic Devices Application Outlook (Revenue, USD Million; 2014 -2025)
  • Skin Cancer Diagnosis
  • Others
Dermatology Treatment Devices Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Light Therapy Devices
  • Lasers
  • Electrosurgical Equipment
  • Liposuction Devices
  • Microdermabrasion Devices
  • Cryotherapy Devices
Dermatology Treatment Devices Application Outlook (Revenue, USD Million; 2014 -2025)
  • Hair Removal
  • Skin Rejuvenation
  • Acne, Psoriasis, and Tattoo Removal
  • Wrinkle Removal and Skin Resurfacing
  • Body Contouring and Fat Removal
  • Vascular and Pigmented Lesion Removal
  • Others
Dermatology Devices End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospitals
  • Clinics
  • Others
Dermatology Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
             
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.